aspirin has been researched along with Fatigue in 15 studies
Aspirin: The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)
acetylsalicylate : A benzoate that is the conjugate base of acetylsalicylic acid, arising from deprotonation of the carboxy group.
acetylsalicylic acid : A member of the class of benzoic acids that is salicylic acid in which the hydrogen that is attached to the phenolic hydroxy group has been replaced by an acetoxy group. A non-steroidal anti-inflammatory drug with cyclooxygenase inhibitor activity.
Fatigue: The state of weariness following a period of exertion, mental or physical, characterized by a decreased capacity for work and reduced efficiency to respond to stimuli.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The purpose of this study was to compare the relative efficacy of acetylsalicylic acid (ASA) and amantadine for the treatment of fatigue in multiple sclerosis (MS)." | 9.16 | Comparison of the effect of aspirin and amantadine for the treatment of fatigue in multiple sclerosis: a randomized, blinded, crossover study. ( Ashtari, F; Janghorbani, M; Shaygannejad, V; Zakeri, H, 2012) |
| "The purpose of this study was to compare the relative efficacy of acetylsalicylic acid (ASA) and amantadine for the treatment of fatigue in multiple sclerosis (MS)." | 5.16 | Comparison of the effect of aspirin and amantadine for the treatment of fatigue in multiple sclerosis: a randomized, blinded, crossover study. ( Ashtari, F; Janghorbani, M; Shaygannejad, V; Zakeri, H, 2012) |
| "Aspirin treatment prevented the symptoms." | 2.72 | Premenstrual multiple sclerosis pseudoexacerbations: Role of body temperature and prevention with aspirin. ( Rodriguez, M; Wingerchuk, DM, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (26.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (26.67) | 29.6817 |
| 2010's | 4 (26.67) | 24.3611 |
| 2020's | 3 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kazama, I | 1 |
| Senzaki, M | 1 |
| Abouhajar, A | 1 |
| Alcock, L | 1 |
| Bigirumurame, T | 1 |
| Bradley, P | 1 |
| Brown, L | 1 |
| Campbell, I | 1 |
| Del Din, S | 1 |
| Faitg, J | 1 |
| Falkous, G | 1 |
| Gorman, GS | 1 |
| Lakey, R | 1 |
| McFarland, R | 1 |
| Newman, J | 1 |
| Rochester, L | 1 |
| Ryan, V | 1 |
| Smith, H | 1 |
| Steel, A | 1 |
| Stefanetti, RJ | 1 |
| Su, H | 1 |
| Taylor, RW | 1 |
| Thomas, NJP | 1 |
| Tuppen, H | 1 |
| Vincent, AE | 1 |
| Warren, C | 1 |
| Watson, G | 1 |
| Mueller, AA | 1 |
| Vaidya, A | 1 |
| Tarter, LL | 1 |
| Klein, JP | 1 |
| Barkoudah, E | 1 |
| Ahrens-Nicklas, RC | 1 |
| Edmondson, AC | 1 |
| Ficicioglu, C | 1 |
| Schaffer, AC | 1 |
| Grad, Y | 1 |
| Ross, JJ | 1 |
| Grad, YH | 1 |
| Seifter, JL | 1 |
| Levy, BD | 1 |
| Loscalzo, J | 1 |
| Shaygannejad, V | 1 |
| Janghorbani, M | 1 |
| Ashtari, F | 1 |
| Zakeri, H | 1 |
| Schwid, SR | 1 |
| Murray, TJ | 1 |
| Wingerchuk, DM | 2 |
| Benarroch, EE | 1 |
| O'Brien, PC | 1 |
| Keegan, BM | 1 |
| Lucchinetti, CF | 1 |
| Noseworthy, JH | 1 |
| Weinshenker, BG | 1 |
| Rodriguez, M | 2 |
| Shin, JI | 1 |
| Lee, JS | 1 |
| Creagan, ET | 1 |
| Buckner, JC | 1 |
| Hahn, RG | 1 |
| Richardson, RR | 1 |
| Schaid, DJ | 1 |
| Kovach, JS | 1 |
| McCarty, DJ | 1 |
| Oka, M | 1 |
| Rekonen, A | 1 |
| Ruotsi, A | 1 |
| Kuikka, J | 1 |
| McGuire, RJ | 1 |
| Wright, V | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Randomised, Double Blinded Cross-over Study Comparing the Efficacy of L-carnitine Versus Placebo in the Treatment of Fatigue in Multiple Sclerosis[NCT01149525] | Phase 3 | 59 participants (Actual) | Interventional | 2010-06-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for aspirin and Fatigue
| Article | Year |
|---|---|
An 8-year-old girl with abdominal pain and mental status changes.
Topics: Abdominal Pain; Acute Disease; Ankle Injuries; Arthralgia; Aspirin; Child; Consciousness Disorders; | 2015 |
5 trials available for aspirin and Fatigue
| Article | Year |
|---|---|
Acipimox in Mitochondrial Myopathy (AIMM): study protocol for a randomised, double-blinded, placebo-controlled, adaptive design trial of the efficacy of acipimox in adult patients with mitochondrial myopathy.
Topics: Adenosine Triphosphate; Adult; Aspirin; Child; Fatigue; Humans; Mitochondrial Myopathies; Muscular D | 2022 |
Comparison of the effect of aspirin and amantadine for the treatment of fatigue in multiple sclerosis: a randomized, blinded, crossover study.
Topics: Adult; Amantadine; Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cross | 2012 |
A randomized controlled crossover trial of aspirin for fatigue in multiple sclerosis.
Topics: Administration, Oral; Adult; Age Factors; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cross-Ov | 2005 |
Premenstrual multiple sclerosis pseudoexacerbations: Role of body temperature and prevention with aspirin.
Topics: Administration, Oral; Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Body Temperature; Cir | 2006 |
Statistical approach to indices of disease activity in rheumatoid arthritis.
Topics: Analysis of Variance; Arthritis, Rheumatoid; Aspirin; Blood Sedimentation; Clinical Trials as Topic; | 1971 |
9 other studies available for aspirin and Fatigue
| Article | Year |
|---|---|
Does immunosuppressive property of non-steroidal anti-inflammatory drugs (NSAIDs) reduce COVID-19 vaccine-induced systemic side effects?
Topics: Acetaminophen; Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; COVID-19 Vaccines; Fati | 2021 |
Caught in a Flare.
Topics: Arthralgia; Aspirin; Atorvastatin; Brain; Diagnosis, Differential; Exanthema; Fatigue; Female; Hemat | 2020 |
Interactive medical case. Bitter pills.
Topics: Acute Disease; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Aspirin; Biopsy; Creatini | 2010 |
Clinical problem-solving. Bitter pills.
Topics: Alcohol Drinking; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Aspirin; Diagnosis, Di | 2010 |
Treating fatigue in patients with MS: one step forward, one step back.
Topics: Amantadine; Aspirin; Benzhydryl Compounds; Central Nervous System; Central Nervous System Stimulants | 2005 |
Can chronic fatigue symptoms associated with nutcracker phenomenon be treated with aspirin?
Topics: Adolescent; Angioplasty, Balloon; Aorta; Aspirin; Child; Child, Preschool; Fatigue; Fatigue Syndrome | 2007 |
An evaluation of recombinant leukocyte A interferon with aspirin in patients with metastatic renal cell cancer.
Topics: Anorexia; Aspirin; Carcinoma, Renal Cell; Combined Modality Therapy; Drug Synergism; Fatigue; Feedin | 1988 |
Measurement of arthritic disease disability.
Topics: Arthritis; Arthritis, Rheumatoid; Aspirin; Disability Evaluation; Fatigue; Humans; Physical Fitness | 1973 |
Measurement of systemic inflammatory activity in rheumatoid arthritis by the 99mTc method.
Topics: Adult; Aged; Arthritis, Rheumatoid; Aspirin; Biomechanical Phenomena; Blood Sedimentation; Depressio | 1973 |